Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
Category
News
FDA Should Recall Software to Protect Patients
News
July 22, 2023
DEA Releases 2024 National Drug Threat Assessment
July 21, 2023
AMA Delegates: Stop Criminalizing Medicine
News
June 14, 2023
DEA Announces Removal of Buprenorphine Waiver Requirements
News
February 23, 2023
Federal Court Overturns CSA Conviction Following Ruan
News
February 23, 2023
HHS Proposes Permanent MOUD Regulatory Flexibilities
News
January 23, 2023
Second Patient Dies After DEA Suspends Physician’s Registration
News
December 15, 2022
Patient Dies After DEA Suspends Physician’s Registration
News
November 7, 2022
Statement on Supreme Court Decision in Ruan v. U.S.
News
June 27, 2022
HHS Expands Access to Buprenorphine for OUD
News
April 27, 2021
ED Visits for Opioid Poisonings Up 29%
News
February 10, 2021
Biden To Reverse Trump X Waiver Policy
News
January 25, 2021
More
